Grounded in the neurosciences, the CANTAB® neuropsychological tests were developed more than 25 years ago at the University of Cambridge by Professors Robbins and Sahakian, to enable detailed translational assessment and evaluation of cognitive function. Lesion, neuroimaging, clinical and psychopharmacological studies have enabled a unique understanding of the structural, clinical and biochemical sensitivities of each of the tests, and other factors affecting performance in these tests - for example, the variation in errors made on the Paired Associates Learning task across the human lifespan is shown below.

CANTAB®, commercialised in 1994, has become the world leader in computerised cognitive testing in its field. It has been used by more than 500 academic institutions worldwide and quoted in over 700 scientific papers. This immense body of work stretching back over the last 25+ years gives CANTAB® an unrivalled scientific heritage and degree of validation.

• CANTAB® tests are sensitive to cognitive changes caused by a wide range of CNS disorders and medication effects.
• Where error scores are a key outcome measure, CANTAB® tests are graded in difficulty to avoid ceiling effects.
• Engaging touch-screen technology maximises compliance.
• The majority of CANTAB® tests are independent of language and culture.